22 May 2024
\n \n \n \nNew comprehensive review provides strong evidence that masks and respirators effectively reduce the transmission of respiratory infections like COVID-19, based on analysis of over 400 studies from multiple disciplines.
\n \n\n \n \n17 May 2024
\n \n \n \nFor World Hypertension Day 2024, discover three of our innovative studies \u2013 SNAP2, SHIP, and OPTIMISE 2 \u2013 aiming to improve blood pressure management across the life cycle through technology and patient involvement.
\n \n\n \n \n19 April 2024
\n \n \n \nThe PANORAMIC PRINCIPLE art exhibition, by CTU artist-in-residence Tanya Poole, was unveiled at the PRINCIPLE-PANORAMIC Celebratory Symposium this week. The portraits interpret the human experience of conducting and participating in the trials and honour the diverse array of participants, researchers, and medical professionals whose inclusive efforts set global benchmarks and transformed lives.
\n \n\n \n \n18 April 2024
\n \n \n \nCollaborative research, led from NDPCHS and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.
\n \n\n \n \n17 April 2024
\n \n \n \nResearchers, clinicians, supporters and PPI contributors gathered on Monday to celebrate the innovative PRINCIPLE and PANORAMIC clinical trials that evaluated potential treatments for COVID-19 during the pandemic and broke recruitment records for community-based trials in doing so. Both trials were run by the Clinical Trails Unit (CTU) in NDPCHS.
\n \n\n \n \n21 March 2024
\n \n \n \nCelebrate the resilience and collaboration behind Oxford's groundbreaking PANORAMIC and PRINCIPLE COVID-19 trials through \"The PANORAMIC PRINCIPLE\" exhibition. Artist Tanya Poole's powerful portraits honour the diverse array of participants, researchers, and medical professionals whose inclusive efforts set global benchmarks and transformed lives. An inspiring tribute to human determination in the face of adversity.
\n \n\n \n \n13 March 2024
\n \n \n \nNew research led by the University of Oxford has concluded that the antiparasitic drug ivermectin does not provide clinically meaningful benefits for treating COVID-19 in a largely vaccinated population.
\n \n\n \n \n7 March 2024
\n \n \n \nA study led by NDPCHS Senior Qualitative Researcher Dr Aleksandra Borek reached number five on the BJGP Open\u2019s top 10 most read articles of 2023 list.
\n \n\n \n \n28 February 2024
\n \n \n \nVirginia Zarama is the recipient of this year's Kellogg College Gillian Nicholls Prize for her MSc in Evidence-Based Health Care dissertation.
\n \n\n \n \n26 February 2024
\n \n \n \nNew research published in Nature Communications suggests that the currently recommended five-day course of molnupiravir, an antiviral treatment, may not be long enough to treat COVID-19.
\n \n\n \n \n23 February 2024
\n \n \n \nOn Tuesday 20 February, NDPCHS held our first Research Showcase. The valuable day brought together staff and students from across the department to share and discuss new research findings, seek collaboration for projects, and propose innovative \u2018dangerous ideas\u2019.
\n \n\n \n \n15 February 2024
\n \n \n \nA new study from researchers in our department provides reassuring evidence that COVID-19 vaccines are safe and effective for people with blood cancers, despite their vulnerable immune systems.
\n \n\n \n \n13 February 2024
\n \n \n \nA team of scientists and experts have been awarded funding to evaluate the new National Health Service Pharmacy First service.
\n \n\n \n \n9 February 2024
\n \n \n \nTwo articles, led or co-authored by Oxford researchers in the Nuffield Department of Primary Care Health Sciences, made the top 10 list of most read research articles in the BJGP for 2023.
\n \n\n \n \n2 February 2024
\n \n \n \nA new study from the Nuffield Department of Primary Care Health Sciences, University of Oxford, and the University of Bristol, shows that an adapted version of an established domestic violence training and support programme can significantly improve GPs\u2019 ability to identify and assist patients experiencing domestic violence and abuse.
\n \n\n \n \n28 January 2024
\n \n \n \nA new evaluation from the University of Oxford\u2019s ongoing PANORAMIC trial suggests that an antiviral treatment, called molnupiravir, used to treat COVID-19 may not be cost-effective at its current price of \u00a3513 per course, compared to usual NHS care and support, in the first six months after infection. However, it may be beneficial for patients over the age of 75.
\n \n\n \n \n2 January 2024
\n \n \n \nThe Nuffield Department of Primary Care Health Sciences hosts its second career pathways event for undergraduate and graduate medical students.
\n \n\n \n \n29 December 2023
\n \n \n \nA new University of Oxford-led study in UK general practice shows that staff need more and different training to equip them for delivering remote healthcare.
\n \n\n \n \n29 November 2023
\n \n \n \nWhile most remote GP consultations are safe, the 'Remote by Default' study finds that GP consultations conducted remotely carry more risk for patients with some urgent conditions.
\n \n\n \n \n28 November 2023
\n \n \n \nThe training initiative builds the foundations to explore further collaborations encompassing joint research efforts, leadership programmes, and a shared commitment to advancing clinical trials.
\n \n\n \n \n